Drug name - Airduo Digihaler

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US7540282 TEVA PHARM Reservoir pressure system for medicament inhaler May, 2023

(7 months from now)

US7540282

(Pediatric)

TEVA PHARM Reservoir pressure system for medicament inhaler Nov, 2023

(1 year, 1 month from now)

US9616024 TEVA PHARM Process for preparing a medicament Sep, 2024

(1 year, 11 months from now)

US9987229 TEVA PHARM Process for preparing a medicament Sep, 2024

(1 year, 11 months from now)

US9616024

(Pediatric)

TEVA PHARM Process for preparing a medicament Mar, 2025

(2 years from now)

US9987229

(Pediatric)

TEVA PHARM Process for preparing a medicament Mar, 2025

(2 years from now)

US9463288 TEVA PHARM Dry powder inhalation apparatus May, 2025

(2 years from now)

US10765820 TEVA PHARM Dry powder inhalation apparatus May, 2025

(2 years from now)

US9463288

(Pediatric)

TEVA PHARM Dry powder inhalation apparatus Nov, 2025

(3 years from now)

US10765820

(Pediatric)

TEVA PHARM Dry powder inhalation apparatus Nov, 2025

(3 years from now)

US8651103 TEVA PHARM Dry powder inhalation apparatus Mar, 2028

(5 years from now)

US8651103

(Pediatric)

TEVA PHARM Dry powder inhalation apparatus Sep, 2028

(6 years from now)

US10195375 TEVA PHARM Airflow adaptor for a breath-actuated dry powder inhaler Feb, 2031

(8 years from now)

US10022510 TEVA PHARM Dose counters for inhalers, inhalers and methods of assembly thereof May, 2031

(8 years from now)

US9731087 TEVA PHARM Dose counter for inhaler having a bore and shaft arrangement May, 2031

(8 years from now)

US10124131 TEVA PHARM Dose counter for inhaler having an anti-reverse rotation actuator May, 2031

(8 years from now)

US9216260 TEVA PHARM Dose counters for inhalers, inhalers and methods of assembly thereof Jun, 2031

(8 years from now)

US10195375

(Pediatric)

TEVA PHARM Airflow adaptor for a breath-actuated dry powder inhaler Aug, 2031

(8 years from now)

US10022510

(Pediatric)

TEVA PHARM Dose counters for inhalers, inhalers and methods of assembly thereof Nov, 2031

(9 years from now)

US9731087

(Pediatric)

TEVA PHARM Dose counter for inhaler having a bore and shaft arrangement Nov, 2031

(9 years from now)

US10124131

(Pediatric)

TEVA PHARM Dose counter for inhaler having an anti-reverse rotation actuator Nov, 2031

(9 years from now)

US9216260

(Pediatric)

TEVA PHARM Dose counters for inhalers, inhalers and methods of assembly thereof Dec, 2031

(9 years from now)

US10561808 TEVA PHARM Dose counter for inhaler having an anti-reverse rotation actuator Jan, 2032

(9 years from now)

US8978966 TEVA PHARM Dose counters for inhalers, inhalers and methods of assembly thereof Jan, 2032

(9 years from now)

US8714149 TEVA PHARM Airflow adaptor for a breath-actuated dry powder inhaler Feb, 2032

(9 years from now)

US10561808

(Pediatric)

TEVA PHARM Dose counter for inhaler having an anti-reverse rotation actuator Jul, 2032

(9 years from now)

US8978966

(Pediatric)

TEVA PHARM Dose counters for inhalers, inhalers and methods of assembly thereof Jul, 2032

(9 years from now)

US8714149

(Pediatric)

TEVA PHARM Airflow adaptor for a breath-actuated dry powder inhaler Aug, 2032

(9 years from now)

US9066957 TEVA PHARM Dry powder inhaler Oct, 2034

(12 years from now)

US9415008 TEVA PHARM Dry powder inhaler Oct, 2034

(12 years from now)

US9415008

(Pediatric)

TEVA PHARM Dry powder inhaler Apr, 2035

(12 years from now)

US9066957

(Pediatric)

TEVA PHARM Dry powder inhaler Apr, 2035

(12 years from now)

US9782551 TEVA PHARM Compliance monitoring module for a breath-actuated inhaler Aug, 2035

(12 years from now)

US9782550 TEVA PHARM Compliance monitoring module for a breath-actuated inhaler Aug, 2035

(12 years from now)

US10918816 TEVA PHARM Compliance monitoring module for a breath-actuated inhaler Dec, 2035

(13 years from now)

US9782551

(Pediatric)

TEVA PHARM Compliance monitoring module for a breath-actuated inhaler Feb, 2036

(13 years from now)

US9782550

(Pediatric)

TEVA PHARM Compliance monitoring module for a breath-actuated inhaler Feb, 2036

(13 years from now)

US10918816

(Pediatric)

TEVA PHARM Compliance monitoring module for a breath-actuated inhaler Jun, 2036

(13 years from now)

US10569034 TEVA PHARM Compliance monitoring module for a breath-actuated inhaler Aug, 2036

(13 years from now)

US10569034

(Pediatric)

TEVA PHARM Compliance monitoring module for a breath-actuated inhaler Feb, 2037

(14 years from now)

US11000653 TEVA PHARM Inhaler Dec, 2038

(16 years from now)

US11000653

(Pediatric)

TEVA PHARM Inhaler Jun, 2039

(16 years from now)

US11173259 TEVA PHARM Drug delivery device with electronics and power management Jul, 2040

(17 years from now)

Drugs and Companies using FLUTICASONE PROPIONATE; SALMETEROL XINAFOATE ingredient

Treatment: Treatment of asthma

Dosage: POWDER;INHALATION

More Information on Dosage
Strength Dosage Availability
0.055MG/INH;EQ 0.014MG BASE/INH POWDER;INHALATION Prescription
0.113MG/INH;EQ 0.014MG BASE/INH POWDER;INHALATION Prescription
0.232MG/INH;EQ 0.014MG BASE/INH POWDER;INHALATION Prescription

availability in other generic markets.

Click on the highlighted region to filter.